Candy giant Hershey is getting a sales boost from an unexpected consumer segment: users of GLP-1 weight-loss drugs. Hershey CEO Kirk Tanner said in the company’s first-quarter earnings call on Thursday that while appetite suppressants are leading customers to consume smaller portions of popular snacks, the drugs are also boosting demand for breath fresheners. The company … Read more
Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects of the flagship diabetes drug, which is also prescribed for weight loss. In the letter, dated March 5, the FDA cited three deaths among patients receiving … Read more
Novo Nordisk said Tuesday it will slash its prices for Wegovy and Ozempic beginning next year by up to 50%, highlighting the growing competition among pharmaceutical firms for customers seeking weight-loss drugs. The Danish drugmaker said it plans to offer the medicines for $675 per month starting in January 2027, representing a 50% reduction in … Read more